KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Interest Expenses (2016 - 2026)

Medtronic's Interest Expenses history spans 12 years, with the latest figure at $181.0 million for Q1 2026.

  • For Q1 2026, Interest Expenses rose 1.12% year-over-year to $181.0 million; the TTM value through Jan 2026 reached $712.0 million, down 5.94%, while the annual FY2025 figure was $729.0 million, 1.39% up from the prior year.
  • Interest Expenses for Q1 2026 was $181.0 million at Medtronic, roughly flat from $181.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $209.0 million in Q4 2024 and bottomed at $118.0 million in Q4 2022.
  • The 5-year median for Interest Expenses is $176.0 million (2025), against an average of $170.6 million.
  • The largest annual shift saw Interest Expenses surged 52.54% in 2023 before it dropped 13.86% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $118.0 million in 2022, then surged by 52.54% to $180.0 million in 2023, then rose by 16.11% to $209.0 million in 2024, then fell by 13.4% to $181.0 million in 2025, then changed by 0.0% to $181.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Interest Expenses are $181.0 million (Q1 2026), $181.0 million (Q4 2025), and $176.0 million (Q3 2025).